Saros Therapeutics is working to enhance patients' response to immunotherapy by harnessing the STING pathway with a strategy to overcome the limitations of prior STING agonists. In combination with existing immunotherapies, this approach has the potential to enable a safe and more effective immune response against the tumor than with immunotherapy alone.
Company Details
- Employees
- 10
- Address
- Chicago, Us
- Industry
- Biotechnology
- Website
- https://www.sarostx.com/
- HQ
- Chicago
Saros Therapeutics Questions
Saros Therapeutics's website is https://www.sarostx.com/
Saros Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sarostx
Saros Therapeutics has
10 employees.
View email and phone details for 10
employees at Saros Therapeutics.
Saros Therapeutics's industry is
Biotechnology
Saros Therapeutics's top competitors are
Mdi Therapeutics, Inc.,
Affyimmune Therapeutics,
Intero Biosystems,
Onl Therapeutics,
Grove Biopharma, Inc.,
Crosswalk Therapeutics,
Circ Biosciences,
M3d,
Evoq Therapeutics,
Blue Arbor Technologies, Inc..
Saros Therapeutics's categories are Biotechnology
